Post-traumatic stress disorder

Significant Reductions in Panic Disorder and PTSD Symptoms Prompt Children's Community Health Plan to Expand Access to Freespira

Retrieved on: 
Tuesday, September 21, 2021
Adoption, Panic disorder, Safety, Partnership, Health Equity Impact Analysis, Diagnosis, Pharmacy, Carbon dioxide, Health, Hypersensitivity, PDSS, Health status of Asian Americans, Overalls, Restaurant, FDA, Medicaid, Telehealth, Patient, Association for Community Affiliated Plans, Administration, Population, Association, Veteran, Adult, Panic, ACAP, HMO, Communication, Respiration, CCHP, Awareness, Mental health, Tuskegee Veterans Administration Medical Center, Post-traumatic stress disorder, PTSD, Lists of Palestinian rocket attacks on Israel, Quality of life, CO2, Medical device, Health insurance

Then, they targeted members with a formal diagnosis of panic disorder or PTSD based on CCHP's claims data.

Key Points: 
  • Then, they targeted members with a formal diagnosis of panic disorder or PTSD based on CCHP's claims data.
  • "Only 3 percent of our member population had a specific diagnosis of panic disorder or PTSD.
  • Freespira is transforming the treatment of panic disorder and PTSD by addressing the underlying physiological factors of these conditions.
  • Freespira, Inc. is the maker of Freespira, the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder, and post-traumatic stress disorder (PTSD) in just 28 days by training users to normalize respiratory irregularities.

Texas Original Compassionate Cultivation Announces Medical Cannabis Discount for Qualifying Military and First Responders

Retrieved on: 
Tuesday, September 21, 2021
Other Consumer, Women, Seniors, Retail, Other Science, Parenting, Other Professional Services, State, Local, Men, Children, Family, Consumer, Professional Services, Science, Alternative Medicine, Health, Other Education, Specialty, Prescription, Medical cannabis, Veteran, House, Patient, United States Army, Physician, CEO, Medicine, Army, CUP, Post-traumatic stress disorder, Cannabis, PTSD, Anxiety, Drug, Hospital, Health insurance

Texas Original Compassionate Cultivation (TOCC), Texas leading medical cannabis provider, announced it will offer a 20 percent discount on its medicine to military and first responders on the heels of this months expansion of the Texas Compassionate Use Program (CUP).

Key Points: 
  • Texas Original Compassionate Cultivation (TOCC), Texas leading medical cannabis provider, announced it will offer a 20 percent discount on its medicine to military and first responders on the heels of this months expansion of the Texas Compassionate Use Program (CUP).
  • It was a great feeling to pick up my medicine at Texas Original Compassionate Cultivation, said David Bass, a new TOCC patient, United States Army veteran and founder of Texas Veterans for Medical Marijuana.
  • TOCCs 20 percent discount is available to military and first responders who show valid identification when picking up their prescriptions.
  • Texas Original Compassionate Cultivation (TOCC) is the leading licensed medical marijuana producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state.

Blue Heron Neurofeedback and Counseling Announces New Employee & Expansion of Services to Littleton and Gorham, NH Offices

Retrieved on: 
Tuesday, September 21, 2021
Blue heron, Low-threshold treatment programs, Patient, List of counseling topics, Multimedia, Family nurse practitioner, Bachelor, Naropa University, Topical steroid withdrawal, EMDR, Program, Mental health, Post-traumatic stress disorder, Lists of diseases, FNP, Anxiety, Medicine, Online shopping

GORHAM, N.H., Sept. 21, 2021 /PRNewswire/ -- Blue Heron Neurofeedback and Counseling is pleased to announce the official expansion of services and the opening of new offices in Gorham and Littleton.

Key Points: 
  • GORHAM, N.H., Sept. 21, 2021 /PRNewswire/ -- Blue Heron Neurofeedback and Counseling is pleased to announce the official expansion of services and the opening of new offices in Gorham and Littleton.
  • As part of the expansion, Blue Heron Neurofeedback and Counseling is now going to include Medical Assisted Treatment for substance use disorders, which complements their current array of existing counseling services.
  • The services Blue Heron provides include options such as mental health and substance use counseling with licensed clinicians, EMDR therapy, Neurofeedback, and Impaired Driver Care Management Program.
  • Blue Heron Neurofeedback and Counseling was founded by Stacie Leclerc MLADC, LCMHC.

Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference

Retrieved on: 
Monday, September 20, 2021
Biotechnology, Health, Science, Pharmaceutical, Research, Conference, Twitter, Brain, NMDA, APTX, Connective tissue disease, Chronic pain, Government budget balance, Inc., Nasdaq, Central nervous system, Lists of diseases, Post-traumatic stress disorder, Pharmaceutical industry

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021 at 10:00 a.m.

Key Points: 
  • Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021 at 10:00 a.m.
  • Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders.
  • The company has three product candidates in clinical development in central nervous system indications, including chronic pain, post-traumatic stress disorder, and cognitive impairment.
  • For more information, visit www.aptinyx.com or follow Aptinyx on Twitter @Aptinyx .

Wise Food Storage Teams Up with the Boot Campaign to Raise Awareness for Veteran Wellness

Retrieved on: 
Friday, September 17, 2021
Boot Campaign, Chronic pain, Movement, PTSD, SALT, CEO, Veteran, Post-traumatic stress disorder, National Suicide Prevention Week, National Preparedness Month, Health, The Lace, National, Food storage, Learning, Social media, TBI, Insomnia, Awareness, Animal

During this time, make a difference by learning more through Wise Food Storage's dedicated email and social media posts and donating directly to the Boot Campaigns Mission.

Key Points: 
  • During this time, make a difference by learning more through Wise Food Storage's dedicated email and social media posts and donating directly to the Boot Campaigns Mission.
  • Learn more about the two campaigns Wise Food Storage is helping to raise awareness for this September.
  • Wise Food Storage also stands with the Boot Campaign for suicide prevention through their YOU MATTER campaign.
  • Wise Food Storage is also teaming up with the Boot Campaign by offering a special Lace Up America Bundle where you can get a free pair of boots with bundle purchase through September 30th.

Hillcroft Physicians P.A. Opens Their Medical Facility to Afghan Refugees

Retrieved on: 
Thursday, September 16, 2021
Paragon, Pediatrics, PTSD, Hillcroft, CEO, Mental health, Health, Post-traumatic stress disorder, Patient, Refugee, Geriatrics, Medicine, Catholic (term), Physician, Environment, YMCA, GLOBE

has dedicated their time helping Afghan refugees throughout the Houston community.

Key Points: 
  • has dedicated their time helping Afghan refugees throughout the Houston community.
  • The Hillcroft Physicians P.A.
  • has served as a safe and welcoming healthcare facility for new immigrants, especially refugees.
  • At Hillcroft Physicians P.A., their highly trained staff is committed to ensuring people from all walks of life will receive outstanding healthcare services.

Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures

Retrieved on: 
Thursday, September 16, 2021
Biotechnology, Finance, Health, Professional Services, Pharmaceutical, Lists of diseases, U.S. Securities and Exchange Commission, Chronic pain, Security (finance), Achievement, Central nervous system, Trial of the century, Post-traumatic stress disorder, NMDA, Patient, Government budget balance, Connective tissue disease, Private Securities Litigation Reform Act, Nasdaq, APTX, Annual report, Inc., Solution, Growth, COVID-19, Twitter, Brain, Goal, Pharmaceutical industry, Management

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it has entered into a $50 million loan facility and security agreement with K2 HealthVentures (K2HV).

Key Points: 
  • Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it has entered into a $50 million loan facility and security agreement with K2 HealthVentures (K2HV).
  • The funds will provide general growth capital as Aptinyx advances its late-stage clinical pipeline of novel NMDA modulators.
  • We are pleased with the terms of the loan and the flexibility this facility offers to Aptinyx.
  • The K2HV team has an excellent track record of partnering with innovative growth companies and an astute perspective on R&D value creation.

The Physicians Foundation, Dr. Lorna Breen Heroes' Foundation and #FirstRespondersFirst Come Together to Ignite National Action on Physician Suicide

Retrieved on: 
Wednesday, September 15, 2021
Vital signs, Foundation, Occupational burnout, Awareness, Harvard T.H. Chan School of Public Health, Education, PTSD, Suicide, Mental health, Family, Vital, Campaign, Post-traumatic stress disorder, Depression, Health, Social, Patient, Anxiety, Child care, United States Public Health Service, Harvard University, Entertainment Industry Foundation, Thrive Global, View, Better Business Bureau, Practice, Physician, Population, EIF, Food, COVID-19, Multimedia, Department, Public health, Nursing, History, Job satisfaction, Little Heroes Foundation, Research, Culture, Leadership, Medicine

BOSTON, Sept. 15, 2021 /PRNewswire/ -- In recognition of National Physician Suicide Awareness Day (September 17, 2021), The Physicians Foundation, Dr. Lorna Breen Heroes' Foundation and #FirstRespondersFirst have come together to equip physicians, their loved ones, their colleagues, health organizations and others to help prevent physician suicide through Vital Signs: The Campaign to Prevent Physician Suicide .

Key Points: 
  • BOSTON, Sept. 15, 2021 /PRNewswire/ -- In recognition of National Physician Suicide Awareness Day (September 17, 2021), The Physicians Foundation, Dr. Lorna Breen Heroes' Foundation and #FirstRespondersFirst have come together to equip physicians, their loved ones, their colleagues, health organizations and others to help prevent physician suicide through Vital Signs: The Campaign to Prevent Physician Suicide .
  • "Physicians have one of the highest suicide rates of any profession and over half of all physicians know of a physician who has considered, attempted or died by suicide," said Gary Price, M.D., president of The Physicians Foundation.
  • "Our sister, Dr. Lorna Breen, died by suicide on April 26, 2020.
  • The Dr. Lorna Breen Heroes' Foundation is a 501(c)3 non-profit organization founded by the family of Dr. Lorna Breen.

$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins

Retrieved on: 
Wednesday, September 15, 2021
Form 10-K, Pain management, Patient, Post-traumatic stress disorder, Annual report, Solution, Grief, Veterans' affairs, Research, Awareness, Tonix Pharmaceuticals, Veteran, Forward-looking statement, Securities Exchange Act of 1934, Conference, Private Securities Litigation Reform Act, ETF, U.S. Securities and Exchange Commission, Medicine, Therapy, NASDAQ, Article, Exchange-traded fund, Security (finance), Atai, Lists of diseases, Purdue Pharma, Securities Act of 1933, NYSE, Degenerative disease, CALM, Pain, Suicidal ideation, FNM, MSC, NEO, NOT, Neurology, Wellness, Oxycodone, Family, Industry, CSE, Psilocybin, Review, ANY, Addiction, News, Prevalence, Pharmaceutical industry, Financial adviser

A potential $10 billion will be going toward fighting the opioid crisis that killed upward of 500,000 Americans in the past two decades.

Key Points: 
  • A potential $10 billion will be going toward fighting the opioid crisis that killed upward of 500,000 Americans in the past two decades.
  • The Sackler family that owns Purdue Pharma will forfeit ownership of Purdue Pharma and pay $4.5 billion for the damage done by opioids like its best-selling Oxycontin.
  • Revitalist Lifestyle and Wellness Ltd. (CSE:CALM)has just announced it has opened its fifth clinic in Raleigh, North Carolina.
  • Cybin is currently developing a pipeline of psychedelic molecules for treating mental health conditions, including a proprietary formulation of psilocybin.

$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins

Retrieved on: 
Wednesday, September 15, 2021
Form 10-K, Pain management, Patient, Post-traumatic stress disorder, Annual report, Solution, Grief, Veterans' affairs, Research, Awareness, Tonix Pharmaceuticals, Veteran, Forward-looking statement, Securities Exchange Act of 1934, Conference, Private Securities Litigation Reform Act, ETF, U.S. Securities and Exchange Commission, Medicine, Therapy, NASDAQ, Article, Exchange-traded fund, Security (finance), Atai, Lists of diseases, Purdue Pharma, Securities Act of 1933, NYSE, Degenerative disease, CALM, Pain, Suicidal ideation, FNM, MSC, NEO, NOT, Neurology, Wellness, Oxycodone, Family, Industry, CSE, Psilocybin, Review, ANY, Addiction, News, Prevalence, Pharmaceutical industry, Financial adviser

NEW YORK, Sept. 15, 2021 /PRNewswire/ -- The damage done by the opioid epidemic has caused families grief and loss, but recent developments in the case against Purdue Pharma will see some restitution for the family. A potential $10 billion will be going toward fighting the opioid crisis that killed upward of 500,000 Americans in the past two decades. The Sackler family that owns Purdue Pharma will forfeit ownership of Purdue Pharma and pay $4.5 billion for the damage done by opioids like its best-selling Oxycontin. Fortunately, a new flock of companies is upending the traditional view of medicine by providing psychedelic treatments into their research and opening clinics to treat patients. Companies like Revitalist Lifestyle and Wellness Ltd. (CSE:CALM), Atai Life Sciences N.V. (NASDAQ:ATAI), Cybin (NYSE:CYBN), Seelos Therapeutics, Inc. (NASDAQ:SEEL) and Tonix Pharmaceuticals (NASDAQ:TNXP) are researching, developing, and bringing to market new treatments in order to avoid the mistakes of the past.

Key Points: 
  • A potential $10 billion will be going toward fighting the opioid crisis that killed upward of 500,000 Americans in the past two decades.
  • The Sackler family that owns Purdue Pharma will forfeit ownership of Purdue Pharma and pay $4.5 billion for the damage done by opioids like its best-selling Oxycontin.
  • Revitalist Lifestyle and Wellness Ltd. (CSE:CALM)has just announced it has opened its fifth clinic in Raleigh, North Carolina.
  • Cybin is currently developing a pipeline of psychedelic molecules for treating mental health conditions, including a proprietary formulation of psilocybin.